Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01220674 · ClinicalTrials.gov registry record
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 152
- Enrollment target
NCT01220674: Completed study, sponsored by University of Nebraska.
NCT01220674 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 152 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01220674 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 152 participants
- Enrollment target
Study Summary
A computer-based neuropsychological assessment tool is being developed to help primary care physicians detect neurological and psychiatric disorders. The first version will be tested against current tests to confirm the tool's effectiveness. Data will be collected on how well the tool detects disease, how well patients understand the instructions and enjoy performing the tasks, and if particular trials or stimuli are too difficult or too easy for all subjects. Adjustments can then be made to the assessment tool, if needed. The initial participants will be age fifty-five to seventy-five with early dementias or mild cognitive impairment to reduce variability.
Interventions
- OTHER cognitive testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2010-12-15 |
| Est. Completion | 2012-10-31 |
What the finished NCT01220674 record still lists
NCT01220674 is an observational study that tracks outcomes without assigning an intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which cognitive testing is the first listed.
NCT01220674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01220674 about?
NCT01220674 is a clinical study titled "Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment". A computer-based neuropsychological assessment tool is being developed to help primary care physicians detect neurological and psychiatric disorders. The first version will be tested against current tests to confirm the tool's effectiveness. Data will be collected on how well the tool detects diseas...
What is the current status of trial NCT01220674?
This trial is currently completed. The enrollment target is 152 participants. The study started on 2010-12-15. Estimated completion is 2012-10-31.
What interventions are being tested in trial NCT01220674?
The interventions under investigation include: cognitive testing (OTHER).
Who is sponsoring clinical trial NCT01220674?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI